Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01563731

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01563731
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01563731. Randomized; no masking; primary purpose prevention. Start 2013-04 (actual); primary completion 2020-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives
Acronym
ESH-CHL-SHOT
Condition
Stroke
Condition
Hypertension
Intervention (Drug)
all approved antihypertensive drugs; all approved statins
Lead sponsor
Istituto Auxologico Italiano (class: other)
Collaborator
European Society of Hypertension (class: other)
Collaborator
Chinese Hypertension League (class: not stated)

Record details

Record id
cardio:ct-nct01563731
Content hash
80f01545bfb7eaae5ae544aa4f842ba10ade8d297faa3cc14b66969ce2a87c67